InvestorsHub Logo
Followers 6
Posts 310
Boards Moderated 0
Alias Born 03/15/2018

Re: None

Tuesday, 03/09/2021 9:12:18 AM

Tuesday, March 09, 2021 9:12:18 AM

Post# of 1196
New Article by StockMarketRevolution.com

Shareholders of Second Sight Medical Products, Inc. (NASDAQ: EYES) appear to be the happiest on Wall Street. A few days ago, the FDA approved the company’s Argus 2s Retinal Prosthesis System to treat retinitis pigmentosa (RP). As a result, in a few days, the share price increased more than 100%. I believe that the share price may continue its upward trend. Let’s see why.

https://stockmarketrevolution.com/archives/15609